China bans clinical research in germline genome editing as ‘irresponsible’
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
New guideline marks China’s latest effort to tighten ethics oversight after He Jiankui shocked the world with first gene-edited babies.